Research ArticleCellular and Molecular
Dinaciclib, a CDK inhibitor promotes proteasomal degradation of Mcl-1 and enhances ABT-737 mediated cell death in malignant human glioma cell lines
Esther P Jane, Daniel R Premkumar, Jonathon M Cavaleri, Philip A Sutera, Thatchana Rajasekar and Ian Pollack
Journal of Pharmacology and Experimental Therapeutics November 19, 2015, jpet.115.230052; DOI: https://doi.org/10.1124/jpet.115.230052